Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Insulin degludec/insulin aspart (IDegAsp) is a soluble co-formulation of IDeg and IAsp. This pan-Asian, 26-week trial investigated efficacy and safety of IDegAsp vs biphasic insulin aspart 30 (BIAsp 30) in Asian adults with type 2 diabetes (T2DM), inadequately controlled on once- or twice-daily (BID) basal, premixed or self-mixed insulin.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Diabetes Res. Clin. Pract.

Title: Diabetes research and clinical practice

ISSN (Electronic): 1872-8227

ISSN (Print): 0168-8227

Publication date (Electronic): Jan 2015

Volume: 107

Issue: 1

Affiliations

[1 ] Takatsuki Red Cross Hospital, Abuno 1-1-1, Ōsaka, Japan.

[2 ] Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

[3 ] Department of Internal Medicine, Korea University Anam Hospital, 126-1,5-ka,Anam-Dong, Seoul, South Korea.

[4 ] Diabetes Center, Manda Memorial Hospital, 1-1, Minami Nijo, Sapporo, Hokkaido, Japan.

[5 ] Department of Internal Medicine, H.E.C Science Clinic, 4-1-4-102, Yokodai, Yokohama-shi, Kanagawa, Japan.

[6 ] Department of Internal Medicine and Bioengineering, Hanyang University Hospital, Seoul 133-791, South Korea.

[7 ] Global Medical Affairs-Insulin, Novo Nordisk A/S, Vandtårnsvej 114, Søborg, Denmark.

[8 ] Global Development, Novo Nordisk A/S, Vandtårnsvej 114, Søborg, Denmark.

[9 ] Department of Endocrinology MEA, Aarhus University Hospital, Dk-8000 Aarhus C, Denmark. Electronic address: jsc@ki.au.dk.

Article

Publisher Item ID: S0168-8227(14)00426-4

DOI: 10.1016/j.diabres.2014.09.026

PubMed ID: 25498130

SO-VID: 31feb660-e097-4192-9b75-4c8deee29ed6

History

Keywords: HbA(1c),Insulin aspart,Insulin degludec,Type 2 diabetes

Data availability:

Keywords: HbA(1c), Insulin aspart, Insulin degludec, Type 2 diabetes

Comments

Comment on this article

scite_

Cited by 44

See all cited by

- Version 1